Ayuda
Ir al contenido

Dialnet


Resumen de How academic labs can approach the drug discovery process as a way to synergize with big pharma

Arianna Loregian, Giorgio Palù

  • While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus